Ibio Inc (NYSE American:IBIO)
| 1.73 Delayed Data As of Jan 26 |  +0.01 / +0.58%Today’s Change | 0.23 Today|||52-Week Range 7.45 | +64.76% Year-to-Date |
Latest IBIO News | Press Releases
| Why iBio Stock Soared Today Jan 22 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.72 |
| Today’s open | 1.80 |
| Day’s range | 1.72 - 1.80 |
| Volume | 659,475 |
| Average volume (3 months) | 12,238,217 |
| Market cap | $370.6M |
Data as of 3:59pm ET, 01/26/2021
Growth & Valuation
| Earnings growth (last year) | +35.41% |
| Earnings growth (this year) | +71.31% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -18.83% |
| P/E ratio | NM |
| Price/Sales | 85.11 |
| Price/Book | 4.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OGIOrganiGram Holdings ... | +0.19 | +11.66% |
| NATRNatures Sunshine Pro... | -0.02 | -0.13% |
| CDXCChromadex Corp | -0.06 | -1.23% |
| ATOSAtossa Therapeutics ... | -0.37 | -12.42% |
Data as of 7:04pm ET, 01/26/2021
Financials
| Next reporting date | March 3, 2021 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $1.6M |
| Annual profit (last year) | -$16.4M |
| Net profit margin | -1,003.60% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
